Janus kinase and signal transducer and activator of transcription inhibitors in type 1 diabetes and immune checkpointrelated diabetes: current status and future perspectives
Most insurance plans cover the diabetes versions, but insurers often restrict access to the weight-loss versions
Currently, there are no FDA-approved drugs specifically for treating fatty liver directly
The main GLP-1 agonist names in India include semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro), liraglutide (Victoza, Saxenda, Lirafit), dulaglutide (Trulicity), and exenatide (Byetta)
Mossy cell synaptic dysfunction causes memory imprecision via miR-128 inhibition of STIM2 in Alzheimer's disease mouse model
It triggers lipolysis (fat breakdown) without raising IGF-1 levels, which is the main concern with full HGH